Effect of upper limb botulinum toxin injections on impairment, activity, participation, and quality of life among stroke patients

Stroke

Volumn 40, Issue 7, 2009, Pages 2589-2591

  Caty, Gilles D ^a   Detrembleur, Christine ^a   Bleyenheuft, Corinne ^a   Deltombe, Thierry ^b   Lejeune, Thierry M ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b UNIVERSITY HOSPITAL OF MONT GODINNE   (Belgium)

Author keywords

Arm; Botulinum toxins; Spasticity; Stroke

Indexed keywords

BOTULINUM TOXIN; BOTULINUM TOXIN A;

ADULT; AGED; ARM MUSCLE; ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG TOLERABILITY; HUMAN; MUSCLE CONTRACTION; MUSCLE STRENGTH; MUSCLE TONE; NEUROLOGIC DISEASE; PARESIS; PRIORITY JOURNAL; QUALITY OF LIFE; SOCIAL BEHAVIOR; SPASTICITY; STROKE;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; AGED, 80 AND OVER; BOTULINUM TOXIN TYPE A; HUMANS; INJECTIONS, INTRAMUSCULAR; INTERPERSONAL RELATIONS; MIDDLE AGED; MUSCLE STRENGTH; MUSCLE TONUS; MUSCLE, SKELETAL; NEUROMUSCULAR AGENTS; QUALITY OF LIFE; STROKE; UPPER EXTREMITY;

EID: 67650070636     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.108.544346     Document Type: Article

References (10)

1. Simpson DM, Gracies J-M, Graham HK, Miyasaki JM, Naumann M, Russman B, Simpson LL, So Y. Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review): Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2008;70:1691-1698.
2. Elovic E, Brashear A, Kaelin D, Liu J, Millis SR, Barron R, Turkel C. Repeated treatments with botulinum toxin type A produce sustained decreases in the limitations associated with focal upper-limb poststroke spasticity for caregivers and patients. Arch Phys Med Rehabil. 2008;89: 799-806.
3. Brashear A, Gordon MF, Elovic E, Kassicieh VD, Marciniak C, Do M, Lee C-H, Jenkins S, Turkel C. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke. N Engl J Med. 2002;347:395-400.
4. Francisco GE. Botulinum toxin for post-stroke spastic hypertonia: a review of its efficacy and application in clinical practice. Ann Acad Med Singapore. 2007;36:22-30.
5. Lagalla G, Reiter DM, Ceravolo MG, Provinciali L. Post-stroke spasticity with repeated botulinum toxin injections in the upper limb. Am J Phys Med Rehabil. 2000;79:377-384.
6. Slawek J, Bogucki A, Reclawowicz D. Botulinum toxin type A for upper limb spasticity following stroke: an open-label study with individualised, flexible injection regimens. Neurol Sci. 2005;26:32-39.
7. Dobkin BH. Botulinum toxin for spasticity after stroke. N Engl J Med. 2003;342:258-259.
8. Penta M, Tesio L, Arnould C, Zancan A, Thonnard JL. The ABILHAND questionnaire as a measure of manual ability in chronic stroke patients: Rasch-based validation and relationship to upper limb impairment. Stroke. 2001;32:1627-1634.
9. Bouffioulx E, Arnould C, Thonnard JL. SATIS-Stroke: A satisfaction measure of activities and participation in the actual environment experienced by patients with chronic stroke. J Rehabil Med. 2008;40: 836-843.
10. Kamper DG, Harvey RL, Suresh S, Rymer WZ. Relative contributions of neural mechanisms versus muscle mechanics in promoting finger extension deficits following stroke. Muscle Nerve. 2003;28:309 -318.